Craxì A, Di Marco V, Bruno R, Fabiano C
Istituto di Medicina Generale e Pneumologia, Ospedale V Cervello, Università di Palermo, Italy.
Ital J Gastroenterol. 1992 Jan;24(1):19-20; discussion 20-1.
Alpha-interferon (IFN) has been used to treat hepatitis B virus carriers with chronic hepatitis Delta virus superinfection. Although the drug inhibits hepatitis Delta virus replication during administration, long-term clearance of the virus has not been obtained in most patients. The effectiveness of alpha-interferon on chronic HDV infection is therefore questionable. No data are available on acute infection. We report the case of a young, immunocompetent HBsAg carrier in whom hepatitis Delta virus superinfection occurred while he was receiving alpha-interferon in order to reduce high level HBV replication, and followed a peculiar course.
α干扰素(IFN)已被用于治疗慢性丁型肝炎病毒重叠感染的乙肝病毒携带者。尽管该药物在给药期间可抑制丁型肝炎病毒复制,但大多数患者并未实现病毒的长期清除。因此,α干扰素对慢性丁型肝炎病毒感染的有效性值得怀疑。目前尚无关于急性感染的数据。我们报告了一例年轻、免疫功能正常的HBsAg携带者病例,该患者在接受α干扰素以降低高水平乙肝病毒复制时发生了丁型肝炎病毒重叠感染,且病程特殊。